⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30320207 | 0.88 | PTPN7 (0.46) | — | |
| SCHEMBL28166539 | 0.88 | PTPN7 (0.46) | — | |
| SCHEMBL22589834 | 0.88 | — | — | |
| SCHEMBL12817067 | 0.80 | — | — | |
| SCHEMBL55033 | 0.79 | TSHR (0.53) | — | |
| SCHEMBL11854278 | 0.76 | TSHR (0.50) | — | |
| SCHEMBL3156663 | 0.75 | — | — | |
| SCHEMBL56364 | 0.73 | — | — | |
| SCHEMBL302816 | 0.73 | HMGCR (0.56) | — | |
| SCHEMBL5166944 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119020115-A | Cleaning agent composition containing fluorine alkyne and application thereof | 泉州宇极新材料科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-20210079277-A1 | COMPOSITION CONTAINING COMPOUND USEFUL AS REFRIGERANT, DETERGENT, PROPELLANT, OR THE LIKE, AND REFRIGERATING MACHINE, LARGE-SIZED AIR CONDITIONER, OR INDUSTRIAL PROCESS COOLER EACH INCLUDING SAID COMPOSITION | DAIKIN INDUSTRIES, LTD. (JP) | 2021-03-18 | — | — | US | disclosed |
| EP-3626799-A1 | COMPOSITION CONTAINING COMPOUND USEFUL AS REFRIGERANT, DETERGENT, PROPELLANT, OR THE LIKE, AND REFRIGERATING MACHINE, LARGE-SIZED AIR CONDITIONER, OR INDUSTRIAL PROCESS COOLER EACH INCLUDING SAID COMPOSITION | Daikin Industries, Ltd. (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-9839704-B2 | Prosthetic compounds for labeling internalizing biomolecules | DUKE UNIVERSITY (US) | 2017-12-12 | — | — | US | disclosed |
| US-20160074541-A1 | Prosthetic Compounds for Labeling Internalizing Biomolecules | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-17 | — | — | US | disclosed |
| EP-2991687-A1 | PROSTHETIC COMPOUNDS FOR LABELING INTERNALIZING BIOMOLECULES | Duke University (US) | 2016-03-09 | — | — | EP | disclosed |
| WO-2014179715-A1 | PROSTHETIC COMPOUNDS FOR LABELING INTERNALIZING BIOMOLECULES | DUKE UNIVERSITY (US) | 2014-11-06 | — | — | WO | disclosed |
| EP-2144912-A1 | 18 F-LABELLED FOLATES | Merck Eprova AG (CH) | 2010-01-20 | — | — | EP | disclosed |
| WO-2008125615-A1 | 18 F-LABELLED FOLATES | MERCK EPROVA AG (CH) | 2008-10-23 | — | — | WO | disclosed |
| EP-0693924-A4 | METHODS FOR -i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS INC (US) | 1997-08-06 | — | — | EP | disclosed |
| EP-0693924-A1 | METHODS FOR $i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS, INC. (US) | 1996-01-31 | — | — | EP | disclosed |
| WO-1994018954-A1 | METHODS FOR IN VIVO DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS, INC. (US) | 1994-09-01 | — | — | WO | disclosed |